<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>15099590686574</udiDi>
    <basicUdiDi>150995906B74074UC</basicUdiDi>
    <tradeName>ClearLLab Compensation Kit</tradeName>
    <deviceName>ClearLLab Compensation Kit</deviceName>
    <manufacturerName>Beckman Coulter India Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000010115</manufacturerSrn>
    <authorisedRepresentativeName>Beckman Coulter Ireland Inc.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000000886</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0103080101</emdnCode>
    <emdnDescription>ANTIBODIES FOR B AND T-CELL SUBTYPING</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>B74074</reference>
    <placedOnMarketCountry>Ireland</placedOnMarketCountry>
    <lastUpdated>2026-07-01T09:08:33.535Z</lastUpdated>
  </row>
  <row>
    <udiDi>15099590686567</udiDi>
    <basicUdiDi>150995906B74073UA</basicUdiDi>
    <tradeName>ClearLLab LS Lymphoid Screen Reagent</tradeName>
    <deviceName>ClearLLab LS Lymphoid Screen Reagent</deviceName>
    <manufacturerName>Beckman Coulter India Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000010115</manufacturerSrn>
    <authorisedRepresentativeName>Beckman Coulter Ireland Inc.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000000886</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0103080101</emdnCode>
    <emdnDescription>ANTIBODIES FOR B AND T-CELL SUBTYPING</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>B74073</reference>
    <placedOnMarketCountry>Ireland</placedOnMarketCountry>
    <lastUpdated>2026-07-01T09:08:31.143Z</lastUpdated>
  </row>
</eudamedExport>